Similarly, TRIM38-KO aggravated the HFHC-induced glucose metabolic disorder, as evidenced by increased blood glucose levels (Fig. 3B), AUC in GTT (Fig. 3C). Here, TRIM38 is linked to glucose metabolism disease.